Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing
the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease …

Since the rapid onset of the COVID‐19 or SARS‐CoV‐2 pandemic in the world in 2019,
extensive studies have been conducted to unveil the behavior and emission pattern of the …

Background and aims The development of vaccines against COVID-19 has been a global
purpose since the World Health Organization declared the pandemic. People usually use …

Abstract mRNA-lipid nanoparticle (mRNA-LNP) vaccines have proved their efficacy,
versatility and unprecedented manufacturing speed during the COVID-19 pandemic. Here …

The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

Background There are some concerns about the effectiveness of the inactivated and vector-
based vaccines against severe acute respiratory syndrome coronavirus 2 in real-world …

The incidence and death toll due to SARS-CoV-2 infection varied time-to-time; and
depended on several factors, including severity (viral load), immune status, age, gender …

Several countries have made unremitting efforts to develop an optimal vaccine in the fight
against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory …

Menstruation is a monthly shedding of the uterine wall, presented by menstrual bleeding in
women of reproductive age. Menstruation is regulated by fluctuation of estrogen and …

Objective To report the efficacy, safety, and exploratory immunogenicity findings of two 5 µg
doses of the BIV1-CovIran vaccine. Design Randomised, placebo controlled, double blind …